Evidax
Decision-ready evidence, accelerated.
Evidax informs high-stakes decisions in drug development.
We deliver rapid, methodologically rigorous evidence synthesis for HTA submissions, asset benchmarking, and post-marketing safety surveillance.
Our workflows produce submission-grade evidence for clinical development, regulatory, and HTA needs. They combine senior methodologist oversight with proprietary AI-augmented tools, giving drug development teams decision-ready evidence in weeks, not months.
For enquiries:
hello@evidax.co →